IQVIA™ Real-World Insights Bibliography

Budget IMPACT Analysis of a Reduced Maintenance Dose of Certolizumab Pegol in Patients with Axial Spondyloarthritis in the United Kingdom
Author(s): Kiri S, Arteaga Duarte C, Lamotte M, Gerlier L
Affiliations(s): IQVIA HEOR Zaventem
Publication(s):  ISPOR Europe 2020 Virtual conference Milano Nov 16-19 Abstract ID# 107821
Document Type(s): Poster,
Countries: USA,
C:
Y:
Rheumatology,
2020
  L:
A:
English
clinical setting: Secondary care, Cost effectiveness,
  Add to report
 
 
Cost-Effectiveness Analysis of Certolizumab Pegol Versus Secukinumab and Ixekizumab in Non-Radiographic Axial Spondyloarthritis in the U.S
Author(s): Kiri S, Arteaga Duarte Ca, Lee E, Low R, Tsakeu E, Lamotte M, Gerlier L.
Affiliations(s): IQVIA HEOR Zaventem
Publication(s):  AMCP Nexus 2020 Virtual October 19.
Document Type(s): Poster,
Countries: USA,
C:
Y:
Rheumatology,
2020
  L:
A:
English
clinical setting: Secondary care, Cost effectiveness,
  Add to report
 
 
Biological Treatment Patterns with Inflammatory Joint Diseases. Retrospective Study with 4 Years Follow-up
Author(s): Cañete JD1, Naranjo A2, Calvo J3, Ordás C4, Aragón B5, Nocea G5, Roset M6, Fernández-Nebro A7
Affiliations(s): 1 Servicio de Reumatología, Hospital Clínic e IDIBAPS, Barcelona, Spain 2 Departamento de Reumatología, Hospital Dr. Negrín, Universidad de las Palmas de Gran Canaria, Las Palmas de Gran Canaria, Spain 3 Departamento de Reumatología, Hospital General Universitario de Valencia, Valencia, Spain 4 Departamento de Reumatología, Hospital de Cabueñes, Gijón, Spain 5 Departamento de Health Economics and Outcomes Research, MSD, Madrid, Spain 6 IQVIA, Barcelona, Spain 7 Departamento de Reumatología, Instituto de Investigación Biomédica (IBIMA), Hospital Regional Universitario de Málaga, Universidad de Málaga, Málaga, Spain
Publication(s):  Reumatol Clin. 2019 Jan 28. pii: S1699-258X(18)30259-6
Document Type(s): Article,
Countries: Spain,
Click here for the abstract
C:
Y:
Rheumatology,
2019
  L:
A:
Spanish
Population Based Study, Survey research,
  Add to report
 
 
Evaluation of the Effectiveness of Risk Minimisation Measures Targeting Physicians on Prescribing Practices of Thiocolchicoside Containing Medicinal Products for Systemic Use
Author(s): Jouaville LS, Ehrhardt C, Kürzinger ML, de Voogd H, Toussi M
Affiliations(s): IQVIA
Publication(s):  Epidemiology (Sunnyvale) 9: 372. DOI: 10.4172/2161-1165.1000372
Document Type(s): Article,
Countries: France, Greece, Italy, Portugal,
Click here for the abstract
C:
Y:
Musculoskeletal disease, Rheumatology, Risk Management & REMS,
2019
  L:
A:
English
Survey research,
  Add to report
 
 
Reduction in the Utilization of Prednisone or Methotrexate in Canadian Claims Data Following Initiation of Etanercept in Pediatric Patients with Juvenile Idiopathic Arthritis
Author(s): Majed M M Khraishi1, Brad Millson2, John Woolcott3, Lisa Marshall4 and Heather Jones4
Affiliations(s): 1Memorial University of Newfoundland, St John's, NF, Canada, 2IQVIA, Kanata, ON, Canada, 3Global Outcomes & Evidence, Pfizer, Collegeville, PA, 4Pfizer, Collegeville, PA
Publication(s):  Annals of the Rheumatic Diseases 2018;77:494.
Document Type(s): Article,
Countries: Canada,
Click here for the abstract
C:
Y:
Pediatrics, Rheumatology,
2019
  L:
A:
English
Longitudinal study, Retrospective database analysis,
  Add to report
 
 
Real-world utilization of methotrexate or prednisone co-therapy with etanercept among Canadian patients with rheumatoid arthritis: a retrospective cohort study
Author(s): Majed Khraishi, Jelena Ivanovic, Yvonne Zhang, Brad Millson, Marie-Josee Brabant, John Woolcott, Heather Jones & Cinzia Curiale
Affiliations(s): 
Publication(s):  Journal of Current Medical Research and Opinion, Accepted author version posted online: 25 Jun 2019, Published online: 10 Jul 2019
Document Type(s): Article,
Countries: Canada,
Click here for the abstract
C:
Y:
Rheumatology,
2019
  L:
A:
English
Retrospective cohort analysis,
  Add to report
 
 
Cost-effectiveness analysis of baricitinib versus adalimumab for the treatment of moderate-to-severe rheumatoid arthritis in Spain.
Author(s): Schlueter M, Finn E, Díaz S, Dilla T, Inciarte-Mundo J, Fakhouri W.
Affiliations(s): IQVIA, Real World Evidence, London N1 9JY, UK. Lilly Spain, Health Outcomes & RWE, Alcobendas 28108, Spain. Lilly Spain, Medical, Alcobendas 28108, Spain. Lilly, Global Patient Reported Outcomes and Real World Evidence (GPORWE) International, Windlesham, Surrey GU20 6PH, UK.
Publication(s):  Clinicoecon Outcomes Res. 2019 Jun 6;11:395-403
Document Type(s): Article,
Countries: Spain,
Click here for the abstract
C:
Y:
Rheumatology,
2019
  L:
A:
English
Retrospective cohort analysis,
  Add to report
 
 
Assessing Treatment Tolerability for Rheumatoid Arthritis. Validation and Practical Applications of the ?TOL-AR-18 Questionnaire
Author(s): Corominas H, Espadaler L, Gómez A, Ros I, Urruticoechea A, Sarmiento M, Sanmartí R
Affiliations(s): Corominas H.: Rheumatology and Autoimmune diseases Division, Hospital Universitari de Sant Pau & Hospital Dos de Maig, Barcelona, Spain Sarmiento M: Real-World Evidence Solutions, IMS Health, Spain
Publication(s):  Reumatología Clínica 2018; Sep 5. [Epub ahead of print]
Document Type(s): Article,
Countries: Spain,
Click here for the abstract
C:
Y:
Health status & patient reported outcomes, Rheumatology,
2018
  L:
A:
English
Clinical setting: hospital, Observational study,
  Add to report
 
 
Two-year adherence and costs for biologic therapy for rheumatoid arthritis
Author(s): Stolshek BS, Wade S, Mutebi A, De AP, Wade RL, Yeaw J
Affiliations(s): Amgen, IQVIA
Publication(s):  Am J Manag Care
Document Type(s): Article,
Countries: USA,
Click here for the abstract
C:
Y:
Rheumatology,
2018
  L:
A:
English
Cost analysis, Retrospective cohort analysis,
  Add to report
 
 
Canadian Study of Adherence Outcomes in HUMIRA® (Adalimumab) Patients – Three-Year Results from the COMPANION Study in Rheumatology Patients
Author(s): Bessette L1, Millson B2, Sung M2, Gaetano T3, Latour M3, Laliberté MC3
Affiliations(s): 1 Department of Medicine, Laval University, Quebec City, Quebec, Canada 2 IMS Brogan, Kirkland, Quebec, Canada; 3AbbVie Corporation, St. Laurent, Quebec, Canada
Publication(s):  Canadian Rheumatology Association 2017 Scientific Meeting, February 8-11, Ottawa, Canada
Document Type(s): Poster,
Countries: Canada,
Click here for the abstract
C:
Y:
Rheumatology,
2017
  L:
A:
English
Database Study,
  Add to report
 
 
 1 of 11 Next Page Last Page